Flexion Therapeutics appoints Mark Stejbach to board
Mr. Stejbach has more than 25 years of leadership experience in biotech and commercial marketing, sales, managed care, and finance.
Prior to that he served as Senior Vice President and Chief Commercial Officer at Alkermes plc.
Previously, he served at Tengion, Inc. from 2008 to 2012, most recently as Chief Commercial Officer. He previously held senior positions at Merck & Co. and Biogen Idec.
Mr. Stejbach received his MBA from the University of Pennsylvania and a Bachelor of Science in mathematics from Virginia Tech. ■
LATEST MOVES FROM Massachusetts
- Chiasma re-appoints Roni Mamluk to board
- BayCoast Bank appoints James Wallace as CFO
- Pulmatrix appoints Amit D. Munshi to board
- Syros Pharmaceuticals appoints Srinivas Akkaraju to board
- Merrimack Pharma names Sergio Santillana as CMO
More inside POST